Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
Key claim: The FDA is classifying the combined acoustic and electrical external stimulation device for tinnitus relief into Class II (special controls), establishing a regulatory pathway that reduces burdens and enhances patient access to this innovative device.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the combined acoustic and electrical external stimulation device for the relief of tinnitus into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the combined acoustic and electrical external stimulation device for the relief of tinnitus. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Why this matters
Classifying this combined acoustic and electrical tinnitus stimulation device as Class II with special controls creates a defined 510(k) pathway for future devices of this type, which typically lowers development costs and speeds market entry compared with premarket approval. For patients suffering from tinnitus — a condition with limited effective treatments — this regulatory clarity can expand access to a novel non-pharmacologic option. It also signals FDA acceptance of combined-modality neuromodulation approaches in the ENT device space.